Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | USP2 | O75604 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | DHCR24 | Q15392 | 6/20 | 0.51 |
| ▸ | CDC25B | P30305 | 2/20 | 0.46 |
| ▸ | CDC25A | P30304 | 1/20 | 0.46 |
| ▸ | SRD5A1 | P18405 | 6/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14415422 | 1.00 | MEN1 (0.68) | MEN1KMT2AUSP2ALDH1A1MAPT | |
| SCHEMBL12883833 | 1.00 | MEN1 (0.68) | MEN1KMT2AUSP2ALDH1A1MAPT | |
| SCHEMBL13077330 | 1.00 | MEN1 (0.68) | MEN1KMT2AUSP2ALDH1A1MAPT | |
| SCHEMBL12869820 | 1.00 | MEN1 (0.68) | MEN1KMT2AUSP2ALDH1A1MAPT | |
| SCHEMBL7797018 | 1.00 | MEN1 (0.68) | MEN1KMT2AUSP2ALDH1A1MAPT | |
| SCHEMBL12884155 | 1.00 | MEN1 (0.68) | MEN1KMT2AUSP2ALDH1A1MAPT | |
| SCHEMBL12869828 | 0.91 | CYP3A4 (0.60) | MEN1KMT2AUSP2ALDH1A1MAPT | |
| SCHEMBL12869769 | 0.91 | CYP3A4 (0.60) | MEN1KMT2AUSP2ALDH1A1MAPT | |
| SCHEMBL12869841 | 0.91 | CYP3A4 (0.60) | MEN1KMT2AUSP2ALDH1A1MAPT | |
| SCHEMBL12869768 | 0.91 | CYP3A4 (0.60) | MEN1KMT2AUSP2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10078091-B2 | Analysis of a panel of cerebrotendinous xanthomatosis biomarkers using site specific derivation and LC/MS/MS workflow | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2018-09-18 | — | — | US | claimed |
| EP-2850430-B1 | ANALYSIS OF A PANEL OF CEREBROTENDINOUS XANTHOMATOSIS BIOMARKERS USING SITE SPECIFIC DERIVATION AND LC/MS/MS WORKFLOW | DH TECHNOLOGIES DEV PTE LTD (SG) | 2017-04-19 | — | — | EP | claimed |
| US-20150323554-A1 | ANALYSIS OF A PANEL OF CEREBROTENDINOUS XANTHOMATOSIS BIOMARKERS USING SITE SPECIFIC DERIVATION AND LC/MS/MS WORKFLOW | DH TECHNOLOGIES DEVELOPMENT PTE. LTD (SG) | 2015-11-12 | — | — | US | claimed |
| EP-2850430-A1 | ANALYSIS OF A PANEL OF CEREBROTENDINOUS XANTHOMATOSIS BIOMARKERS USING SITE SPECIFIC DERIVATION AND LC/MS/MS WORKFLOW | Dh Technologies Development Pte. Ltd. (SG) | 2015-03-25 | — | — | EP | claimed |
| WO-2013171568-A1 | ANALYSIS OF A PANEL OF CEREBROTENDINOUS XANTHOMATOSIS BIOMARKERS USING SITE SPECIFIC DERIVATION AND LC/MS/MS WORKFLOW | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2013-11-21 | — | — | WO | claimed |
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | THE BROAD INSTITUTE, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-20250376656-A1 | MASSIVELY PARALLEL ON-CHIP CONSTRUCTION OF SYNTHETIC MICROBIAL COMMUNITIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-12-11 | — | — | US | disclosed |
| US-20220228190-A1 | MASSIVELY PARALLEL ON-CHIP CONSTRUCTION OF SYNTHETIC MICROBIAL COMMUNITIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2022-07-21 | — | — | US | disclosed |
| CN-110313532-A | A kind of pilose antler beauty treatment mind easing tea and preparation method thereof | 西安文理学院 | 2019-10-11 | — | — | CN | disclosed |
| US-10078091-B2 | Analysis of a panel of cerebrotendinous xanthomatosis biomarkers using site specific derivation and LC/MS/MS workflow | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2018-09-18 | — | — | US | disclosed |
| EP-2850430-B1 | ANALYSIS OF A PANEL OF CEREBROTENDINOUS XANTHOMATOSIS BIOMARKERS USING SITE SPECIFIC DERIVATION AND LC/MS/MS WORKFLOW | DH TECHNOLOGIES DEV PTE LTD (SG) | 2017-04-19 | — | — | EP | disclosed |
| US-20150323554-A1 | ANALYSIS OF A PANEL OF CEREBROTENDINOUS XANTHOMATOSIS BIOMARKERS USING SITE SPECIFIC DERIVATION AND LC/MS/MS WORKFLOW | DH TECHNOLOGIES DEVELOPMENT PTE. LTD (SG) | 2015-11-12 | — | — | US | disclosed |
| EP-2850430-A1 | ANALYSIS OF A PANEL OF CEREBROTENDINOUS XANTHOMATOSIS BIOMARKERS USING SITE SPECIFIC DERIVATION AND LC/MS/MS WORKFLOW | Dh Technologies Development Pte. Ltd. (SG) | 2015-03-25 | — | — | EP | disclosed |
| WO-2013171568-A1 | ANALYSIS OF A PANEL OF CEREBROTENDINOUS XANTHOMATOSIS BIOMARKERS USING SITE SPECIFIC DERIVATION AND LC/MS/MS WORKFLOW | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2013-11-21 | — | — | WO | disclosed |
| EP-2269630-A1 | Novel anti-nematode therapies targetting STRM-1 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2011-01-05 | — | — | EP | disclosed |
| WO-2010146062-A2 | NOVEL ANTI-HELMINTHIC THERAPIES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2010-12-23 | — | — | WO | disclosed |
| US-20100009927-A1 | Anti-Inflammatory and Anti-Allergy Extracts from Nettle | HERBALSCIENCE GROUP LLC (US) | 2010-01-14 | — | — | US | disclosed |
| US-20020183283-A1 | Meiosis regulating compounds | FAARUP PETER (DK) | 2002-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020183283-A1 | Meiosis regulating compounds | SREBF2, SREBF1, TRIP13 | MEN1 2167/4885KMT2A 1254/4885USP2 1879/4885 |
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | STUB1, SAMM50, CD14 | MEN1 4321/4885KMT2A 4140/4885USP2 806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.